Future Oncol. 2014 May;10(7):1133-6. doi: 10.2217/fon.14.46.
Thomas Feeley is the Helen Shafer Fly Distinguished Professor of Anesthesiology, and the Head of the Institute for Cancer Care Innovation at the University of Texas MD Anderson Cancer Center (TX, USA), which he has led since its formation in 2008. He received his undergraduate degree and M.D. from Boston University (MA, USA) and trained in anesthesiology and critical care medicine at Harvard’s Beth Israel Hospital in Boston. He was a faculty member at Stanford University (CA, USA) for 19 years prior to moving to The University of Texas MD Anderson Cancer Center in 1997 to lead the then newly created Division of Anesthesiology and Critical Care. Dr Feeley served on the Institute of Medicine’s Committee on Improving the Quality of Cancer Care: Addressing the Challenges of an Aging Population that published its report in September of 2013. He was recently appointed by Texas Governor Rick Perry to the board of directors of the Texas Institute for Health Care Quality and Efficiency. In addition to his research and administrative roles, Dr Feeley provides patient care services in the delivery of anesthesia.
托马斯·菲利（Thomas Feeley）是海伦·谢弗·弗莱杰出麻醉学教授，也是德克萨斯大学 MD 安德森癌症中心（美国德克萨斯州）癌症护理创新研究所的所长，自 2008 年成立以来一直领导该研究所。他本科和医学博士均毕业于波士顿大学（美国马萨诸塞州），并在波士顿哈佛贝斯以色列医院接受过麻醉学和重症监护医学培训。在 1997 年搬到达特茅斯 MD 安德森癌症中心之前，他在美国斯坦福大学（加利福尼亚州）任教 19 年，领导当时新成立的麻醉学和重症监护医学系。菲利博士曾任职于美国医学研究所改善癌症护理质量委员会，该委员会于 2013 年 9 月发布了报告，解决人口老龄化的挑战。最近，他被德克萨斯州州长里克·佩里（Rick Perry）任命为德克萨斯州医疗保健质量和效率研究所董事会成员。除了他的研究和管理角色外，菲利博士还在提供麻醉服务的过程中为患者提供护理服务。
